As of 2024-12-12, the Fair Value of Anika Therapeutics Inc (ANIK) is -33.28 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 17.87 USD, the upside of Anika Therapeutics Inc is -286.25%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 27.20 | -24.00 | 4.10 | -14.90 | -82.67 | -18.05 |
| YoY growth | 45.45% | -188.24% | 117.08% | -463.41% | -454.81% | -188.78% |
| Market Cap (mil) | 261.80 |
| P/E | |
| Forward P/E |
| EPS | -6.66 |
| Avg earnings growth rate | -188.78% |
| TTM earnings | -97.52 |